| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2008PLoSO...3.2908B |
| P356 | DOI | 10.1371/JOURNAL.PONE.0002908 |
| P932 | PMC publication ID | 2483419 |
| P698 | PubMed publication ID | 18682840 |
| P5875 | ResearchGate publication ID | 23151820 |
| P50 | author | Didier Raoult | Q915676 |
| Hervé Richet | Q114421288 | ||
| Jean-Christophe Dubus | Q114779819 | ||
| Nathalie Stremler | Q114779820 | ||
| Jacques Sarles | Q114779821 | ||
| Martine Reynaud-Gaubert | Q42215588 | ||
| Fadi Bittar | Q49360813 | ||
| P2860 | cites work | Inquilinus limosus in patients with cystic fibrosis, Germany | Q24620282 |
| 16S ribosomal DNA amplification for phylogenetic study | Q24681548 | ||
| Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA | Q28119124 | ||
| Bacterial diversity in human subgingival plaque | Q28190392 | ||
| Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms | Q29615294 | ||
| Novel bacterium isolated from a lung transplant patient with cystic fibrosis. | Q30584467 | ||
| Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov | Q30695296 | ||
| Molecular analysis of bacteria in periodontitis: evaluation of clone libraries, novel phylotypes and putative pathogens | Q30885828 | ||
| Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. | Q31030261 | ||
| Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets. | Q33185288 | ||
| Identification of bacteria in endodontic infections by sequence analysis of 16S rDNA clone libraries | Q33230642 | ||
| Molecular analysis of bacteria in asymptomatic and symptomatic endodontic infections | Q33233827 | ||
| Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis | Q33310144 | ||
| Molecular identification of microorganisms from endodontic infections | Q33973436 | ||
| Molecular typing of the bacterial flora in sputum of cystic fibrosis patients. | Q51653034 | ||
| Clonal analysis of Inquilinus limosus isolates from six cystic fibrosis patients and specific serum antibody response. | Q54579124 | ||
| Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis | Q57913654 | ||
| The incidence of anaerobes in the sputum of patients with cystic fibrosis | Q68752411 | ||
| Inquilinus limosus isolated from a cystic fibrosis patient: first UK report | Q81383810 | ||
| Antimicrobial susceptibility and clinical sources of Dolosigranulum pigrum cultures | Q33980129 | ||
| Identification of candidate periodontal pathogens and beneficial species by quantitative 16S clonal analysis | Q34041621 | ||
| Clinical and microbiological features of Inquilinus sp. isolates from five patients with cystic fibrosis. | Q34041641 | ||
| Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. | Q34073568 | ||
| Defining the normal bacterial flora of the oral cavity | Q34143846 | ||
| Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation | Q34157044 | ||
| Analysis of 525 samples to determine the usefulness of PCR amplification and sequencing of the 16S rRNA gene for diagnosis of bone and joint infections | Q34431789 | ||
| Infection control in cystic fibrosis | Q35545544 | ||
| Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling. | Q35638889 | ||
| Molecular analysis of oral and respiratory bacterial species associated with ventilator-associated pneumonia | Q35784438 | ||
| Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice | Q36095028 | ||
| Dolosigranulum pigrum causing nosocomial pneumonia and septicemia | Q36098701 | ||
| Aminoglycosides versus bacteria--a description of the action, resistance mechanism, and nosocomial battleground. | Q36893723 | ||
| characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling | Q37597340 | ||
| Ventilator-associated pneumonia caused by Dolosigranulum pigrum | Q38474600 | ||
| Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. | Q40624126 | ||
| Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis. | Q41481789 | ||
| Superiority of molecular techniques for identification of gram-negative, oxidase-positive rods, including morphologically nontypical Pseudomonas aeruginosa, from patients with cystic fibrosis | Q41819863 | ||
| Antimicrobial susceptibilities and clinical sources of Dialister species. | Q42909059 | ||
| Inquilinus limosus and cystic fibrosis | Q43230341 | ||
| Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients | Q43447859 | ||
| Staphylococcus aureus small colony variants: difficult to diagnose and difficult to treat | Q44164967 | ||
| Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates | Q45129729 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cystic fibrosis | Q178194 |
| emerging pathogen | Q108429945 | ||
| P304 | page(s) | e2908 | |
| P577 | publication date | 2008-08-06 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients | |
| P478 | volume | 3 |
| Q59634877 | A survey on pulmonary pathogens and their antibiotic susceptibility among cystic fibrosis patients |
| Q35113179 | Adaptation of Pseudomonas aeruginosa in Cystic Fibrosis airways influences virulence of Staphylococcus aureus in vitro and murine models of co-infection |
| Q46259966 | Airway microbiota across age and disease spectrum in cystic fibrosis |
| Q21562196 | Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients |
| Q38026069 | Anaerobic Pseudomonas aeruginosa and other obligately anaerobic bacterial biofilms growing in the thick airway mucus of chronically infected cystic fibrosis patients: an emerging paradigm or "Old Hat"? |
| Q35598658 | Analysis of microbiota in stable patients with chronic obstructive pulmonary disease. |
| Q33743766 | Analysis of the bacterial communities present in lungs of patients with cystic fibrosis from American and British centers |
| Q34440993 | Analysis of the cystic fibrosis lung microbiota via serial Illumina sequencing of bacterial 16S rRNA hypervariable regions |
| Q33792765 | Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi |
| Q37169933 | Antibiotic resistance in Prevotella species isolated from patients with cystic fibrosis |
| Q37887170 | Antibiotic treatment of CF lung disease: from bench to bedside |
| Q35230652 | Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis |
| Q24619768 | As-yet-uncultivated oral bacteria: breadth and association with oral and extra-oral diseases |
| Q55362858 | Aspergillus fumigatus Inhibits Pseudomonas aeruginosa in Co-culture: Implications of a Mutually Antagonistic Relationship on Virulence and Inflammation in the CF Airway. |
| Q35127881 | Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods |
| Q47097212 | Bacterial infections in patients with primary ciliary dyskinesia: Comparison with cystic fibrosis |
| Q56220182 | Bacteriophages and diffusion of genes encoding antimicrobial resistance in cystic fibrosis sputum microbiota |
| Q37911731 | Bacteriophages as vehicles of the resistome in cystic fibrosis. |
| Q30388877 | Changes in cystic fibrosis airway microbial community associated with a severe decline in lung function |
| Q40499136 | Characterization and Testing the Efficiency of Acinetobacter baumannii Phage vB-GEC_Ab-M-G7 as an Antibacterial Agent |
| Q40642149 | Chelation of Membrane-Bound Cations by Extracellular DNA Activates the Type VI Secretion System in Pseudomonas aeruginosa. |
| Q92901904 | Clinical Outcomes Associated With Escherichia coli Infections in Adults With Cystic Fibrosis: A Cohort Study |
| Q34491552 | Clinical significance of microbial infection and adaptation in cystic fibrosis |
| Q36477037 | Combination of 16S rRNA variable regions provides a detailed analysis of bacterial community dynamics in the lungs of cystic fibrosis patients |
| Q40507596 | Comparative genomics of non-pseudomonal bacterial species colonising paediatric cystic fibrosis patients |
| Q42575595 | Comparing the microbiota of the cystic fibrosis lung and human gut. |
| Q40964077 | Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm. |
| Q28742049 | Culture enriched molecular profiling of the cystic fibrosis airway microbiome |
| Q35763672 | Cystic fibrosis lung microbiome: opportunities to reconsider management of airway infection |
| Q85110286 | Cystic fibrosis: deciphering the complexity |
| Q33705998 | Detection and accurate identification of new or emerging bacteria in cystic fibrosis patients |
| Q55373289 | Detection of Bacteriophage Particles Containing Antibiotic Resistance Genes in the Sputum of Cystic Fibrosis Patients. |
| Q33619114 | Detection of plant DNA in the bronchoalveolar lavage of patients with ventilator-associated pneumonia |
| Q34488114 | Determining the influence of environmental and patient specific factors on the polymicrobial communities of the cystic fibrosis airway. |
| Q33769617 | Development of real-time PCR assays for detection of the Streptococcus milleri group from cystic fibrosis clinical specimens by targeting the cpn60 and 16S rRNA genes |
| Q36187491 | Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota |
| Q46495945 | Discriminating typical and atypical cystic fibrosis-related bacteria by multiplex PNA-FISH. |
| Q34810119 | Dolosigranulum pigrum keratitis: a three-case series |
| Q99581648 | Dolosigranulum pigrum: Predicting Severity of Infection |
| Q33609099 | Emergent bacteria in cystic fibrosis: in vitro biofilm formation and resilience under variable oxygen conditions. |
| Q38211644 | Evolution and impact of bacterial drug resistance in the context of cystic fibrosis disease and nosocomial settings |
| Q99712064 | Fostering Innovation in the Treatment of Chronic Polymicrobial Cystic Fibrosis-Associated Infections Exploring Aspartic Acid and Succinic Acid as Ciprofloxacin Adjuvants |
| Q22001138 | Fungal allergy in asthma-state of the art and research needs |
| Q42268855 | Genome sequence of Microbacterium yannicii, a bacterium isolated from a cystic fibrosis patient |
| Q35074619 | High individuality of respiratory bacterial communities in a large cohort of adult cystic fibrosis patients under continuous antibiotic treatment |
| Q38635041 | How can the cystic fibrosis respiratory microbiome influence our clinical decision-making? |
| Q42246471 | Hypoxia increases antibiotic resistance in Pseudomonas aeruginosa through altering the composition of multidrug efflux pumps |
| Q33557651 | Identification of a siderophore utilization locus in nontypeable Haemophilus influenzae |
| Q39062364 | Impact of polymicrobial biofilms in catheter-associated urinary tract infections. |
| Q34706914 | Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations |
| Q37937558 | Inhaled antibiotics for gram-negative respiratory infections |
| Q38270626 | Levofloxacin inhalation solution for the treatment of chronic Pseudomonas aeruginosa infection among patients with cystic fibrosis |
| Q43018827 | Lung biopsies for interstitial lung disease: the limits of the traditional methods of microbiological identification |
| Q37705435 | Lung infections in cystic fibrosis: deriving clinical insight from microbial complexity |
| Q43477468 | Lung resistome |
| Q37832677 | Lung transplantation: infection, inflammation, and the microbiome |
| Q34181466 | Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patients |
| Q30641042 | Mechanistic model of Rothia mucilaginosa adaptation toward persistence in the CF lung, based on a genome reconstructed from metagenomic data |
| Q34445180 | MetaGeniE: characterizing human clinical samples using deep metagenomic sequencing |
| Q34404215 | Metagenomics and metatranscriptomics: windows on CF-associated viral and microbial communities |
| Q45772438 | Microbial diversity in the sputum of a cystic fibrosis patient studied with 16S rDNA pyrosequencing |
| Q35124580 | Microbiome in cystic fibrosis: Shaping polymicrobial interactions for advances in antibiotic therapy. |
| Q38080967 | Molecular detection of CF lung pathogens: current status and future potential |
| Q34342492 | Molecular detection of eukaryotes in a single human stool sample from Senegal |
| Q38220778 | Molecular revolution in the diagnosis of microbial brain abscesses |
| Q37974314 | Multi-species biofilms: living with friendly neighbors |
| Q35298968 | Mycobacterium chimaera pulmonary infection complicating cystic fibrosis: a case report |
| Q37804379 | New Antimicrobial Strategies in Cystic Fibrosis |
| Q37816407 | New insights into Prevotella diversity and medical microbiology |
| Q37738904 | Optimal airway antimicrobial therapy for cystic fibrosis: the role of inhaled aztreonam lysine |
| Q33647480 | Outbreak of Corynebacterium pseudodiphtheriticum infection in cystic fibrosis patients, France |
| Q45729541 | Phenazine content in the cystic fibrosis respiratory tract negatively correlates with lung function and microbial complexity |
| Q34705295 | Phenotypic and genotypic properties of Microbacterium yannicii, a recently described multidrug resistant bacterium isolated from a lung transplanted patient with cystic fibrosis in France |
| Q54748140 | Phlyctenular keratoconjunctivitis associated with Dolosigranulum pigrum. |
| Q33633034 | Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis. |
| Q38103941 | Pneumonia pathogen detection and microbial interactions in polymicrobial episodes |
| Q34179233 | Polymicrobial challenges to Koch's postulates: ecological lessons from the bacterial vaginosis and cystic fibrosis microbiomes |
| Q40273725 | Presence of Bacteria in Spontaneous Achilles Tendon Ruptures |
| Q57913523 | Prevotella denticolaLipopolysaccharide from a Cystic Fibrosis Isolate Possesses a Unique Chemical Structure |
| Q39029126 | Prevotella intermedia induces severe bacteremic pneumococcal pneumonia in mice with upregulated platelet-activating factor receptor expression |
| Q36558320 | Production of extended-spectrum β-lactamases and the potential indirect pathogenic role of Prevotella isolates from the cystic fibrosis respiratory microbiota |
| Q38270707 | Proteomics of hosts and pathogens in cystic fibrosis |
| Q38273318 | Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs-A Review. |
| Q35788879 | Pulmonary bacterial communities in surgically resected noncystic fibrosis bronchiectasis lungs are similar to those in cystic fibrosis. |
| Q28543599 | Pyocyanina contributory factor in haem acquisition and virulence enhancement of Porphyromonas gingivalis in the lung [corrected] |
| Q37502050 | Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis |
| Q55444974 | Quantitative assessment of individual populations within polymicrobial biofilms. |
| Q90197309 | RNA-based qPCR as a tool to quantify and to characterize dual-species biofilms |
| Q23911842 | Rationale and design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) study. Sarcoidosis protocol |
| Q33770039 | Reliability of quantitative real-time PCR for bacterial detection in cystic fibrosis airway specimens |
| Q34184581 | Repertoire of intensive care unit pneumonia microbiota |
| Q34554419 | Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy |
| Q35866602 | Subgingival Microbial Profiles of Smokers with Periodontitis |
| Q35743588 | The Role of Short-Chain Fatty Acids, Produced by Anaerobic Bacteria, in the Cystic Fibrosis Airway |
| Q34437958 | The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations |
| Q57913623 | The airway microbiome in cystic fibrosis: challenges for therapy |
| Q28730299 | The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management |
| Q92488237 | The anti-sigma factor MucA of Pseudomonas aeruginosa: Dramatic differences of a mucA22 vs. a ΔmucA mutant in anaerobic acidified nitrite sensitivity of planktonic and biofilm bacteria in vitro and during chronic murine lung infection |
| Q35677622 | The bacterial microbiota in inflammatory lung diseases |
| Q33825634 | The changing microbial epidemiology in cystic fibrosis |
| Q35861377 | The cystic fibrosis microbiome in an ecological perspective and its impact in antibiotic therapy |
| Q28476274 | The key role of genomics in modern vaccine and drug design for emerging infectious diseases |
| Q35082308 | The lung mycobiome: an emerging field of the human respiratory microbiome. |
| Q24602074 | The microbiome of the lung |
| Q88003632 | The nasal microbiome in asthma |
| Q33554623 | The role of the bacterial microbiome in lung disease |
| Q34425654 | Three clinically distinct chronic pediatric airway infections share a common core microbiota |
| Q34216149 | Tropheryma whipplei in patients with pneumonia |
| Q37608274 | Update on antibiotics for infection control in cystic fibrosis |
| Q35096250 | Use of denaturing high-performance liquid chromatography (DHPLC) to characterize the bacterial and fungal airway microbiota of cystic fibrosis patients. |
| Q33388535 | Use of pyrosequencing and DNA barcodes to monitor variations in Firmicutes and Bacteroidetes communities in the gut microbiota of obese humans |
| Q35143420 | Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onset |
| Q38185756 | Whole genome sequencing of bacteria in cystic fibrosis as a model for bacterial genome adaptation and evolution |
Search more.